Literature DB >> 1527417

Role of pulmonary phagocytes in host defense against group B streptococci in preterm versus term rabbit lung.

M P Sherman1, J T Johnson, R Rothlein, B J Hughes, C W Smith, D C Anderson.   

Abstract

Intrapulmonary clearance of group B streptococci (GBS) occurred in term rabbits 4 and 8 h after infection; GBS growth was evident in preterm rabbits at 8 h. Bronchoalveolar lavage revealed 17-fold higher numbers of pulmonary alveolar macrophages (PAM) in term versus preterm animals immediately after infection, whereas polymorphonuclear leukocyte (PMNL) recruitment was 13-fold greater in preterm than term rabbits at 8 h. Anti-CD18 monoclonal antibody R15.7 did not reduce PMNL influx or GBS killing in term animals. R15.7 failed to inhibit PMNL influx but augmented GBS growth in preterm animals. R15.7 significantly impaired GBS phagocytosis by preterm and term PMNL in vitro but had no effect on ingestion of GBS by preterm and term PAM. Thus, GBS infection initiates PMNL recruitment into lungs of preterm rabbits by CD18-independent mechanisms, but phagocytosis of GBS by PMNL is largely CD18-dependent. The poorer outcome of GBS pneumonia in preterm versus term newborns may result from low levels of PAM, thereby mandating recruitment of PMNL as a second phagocytic defense.

Entities:  

Mesh:

Year:  1992        PMID: 1527417     DOI: 10.1093/infdis/166.4.818

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

2.  Entry and intracellular survival of group B streptococci in J774 macrophages.

Authors:  P Valentin-Weigand; P Benkel; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus.

Authors:  Debasish Chattopadhyay; Alison J Carey; Elise Caliot; Richard I Webb; James R Layton; Yan Wang; John F Bohnsack; Elisabeth E Adderson; Glen C Ulett
Journal:  Microbes Infect       Date:  2011-01-14       Impact factor: 2.700

4.  Trojan horse effect: phagocyte-mediated Streptococcus iniae infection of fish.

Authors:  Amir Zlotkin; Stefan Chilmonczyk; Marina Eyngor; Avshalom Hurvitz; Claudio Ghittino; Avi Eldar
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Group B streptococci persist inside macrophages.

Authors:  P Cornacchione; L Scaringi; K Fettucciari; E Rosati; R Sabatini; G Orefici; C von Hunolstein; A Modesti; A Modica; F Minelli; P Marconi
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

6.  Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia.

Authors:  R K L Bouhafs; C Jarstrand; B Robertson
Journal:  Lung       Date:  2004       Impact factor: 2.584

7.  Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species.

Authors:  J F Bohnsack; J K Chang; H R Hill
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  In utero ethanol exposure impairs defenses against experimental group B streptococcus in the term Guinea pig lung.

Authors:  Theresa W Gauthier; Paula A Young; Levan Gabelaia; Sonja M Tang; Xiao-Du Ping; Frank L Harris; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

9.  Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia.

Authors:  Elizabeth M Todd; Rashmi Ramani; Taylor P Szasz; S Celeste Morley
Journal:  Sci Adv       Date:  2019-08-14       Impact factor: 14.136

Review 10.  Regulatory mechanisms of neutrophil migration from the circulation to the airspace.

Authors:  Wan-Chi Lin; Michael B Fessler
Journal:  Cell Mol Life Sci       Date:  2021-02-05       Impact factor: 9.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.